Late and booster anti-SARS-CoV-2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al.
Athanasios-Dimitrios BakasisAndreas V GoulesPanayiotis G VlachoyiannopoulosKleopatra BitzogliAthanasios G TzioufasPublished in: ACR open rheumatology (2022)